S.D. Venture Capital Funding Hits $1 Billion in Q2 2024
Learn which local startups received venture capital investments in Q2 2024.
Business San Diego delivers in-depth profiles of founders and insights on the most successful companies, executives, and technologies in San Diego. Subscribe to make sure you don’t miss the next story.
In San Diego, startup funding for the second quarter surpassed $1 billion for the fifth consecutive year, driven by dozens of tech and life science venture capital fundings.
San Diego saw roughly 42 deals in Q2 including four startups raising $100+ million, known as mega-deals.
A significant number of those venture-backed companies included biotech, pharmaceutical and genomics companies.
Globally startup funding reached $79 billion in the first half of the year, up from $71 billion in Q2 2023, according to Crunchbase.
A total of 3 San Diego companies have gone public so far, with at least two more in the pipeline. San Diego life science companies including Boundless Bio, Contineum Therapeutics, and Rapport Therapeutics all went public this year.
High-Level Overview
$1 billion-plus venture capital funding went to San Diego companies.
Top bio deals: Endeavor BioMedicines ($132M), Alterome Therapeutics ($132M)
Top tech deals: Platform Science ($125M), Firestorm Labs ($12.5M)
Top consumer deals: Splash Ventures ($4.5M), Hume Supernatural ($1.5M)
Below are San Diego’s top deals in Q2 2024, including tech, bio, and consumer.